Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study
- PMID: 28864837
- DOI: 10.1007/s00702-017-1781-0
Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study
Abstract
Functional near-infrared spectroscopy (fNIRS) and vagus somatosensory evoked potentials (VSEP) show deviant patterns in subjects with Alzheimer's disease (AD) compared to healthy controls. We now aimed at testing the predictive value of these methods in the early diagnosis of AD. The Vogel study is a prospective, observational, long-term follow-up study with three time points of investigation within 6 years. Residents of the city of Würzburg born between 1936 and 1941 were recruited. Every participant underwent physical, psychiatric, and laboratory examinations, and performed an intense neuropsychological testing as well as VSEP and NIRS according to the published procedures. 604 subjects were included. Mean age of the participants was 73.9 ± 1.55 years. The most frequent pathological physical and laboratory examination results were observed for blood pressure (62%), body weight (54%), HbA1c (16%), cholesterol (42%), and homocysteine (69%). Comprehensive analysis of cognitive testing showed mild cognitive impairment (MCI) in 12.3% of the patients. Concurrent major depression was found in 6.6% of the patients. We observed a high rate of MCI and somatic comorbidity in our cohort. The high rate of vascular risk factors and depressive symptoms, all of which are known risk factors of AD, is consistent with the notion that there are multiple options to prevent or postpone the onset of AD in a geriatric population like the one of the Vogel studies.
Keywords: Alzheimer’s disease; Early diagnosis; Evoked potentials; Near-infrared spectroscopy; Predictive value; Vagus nerve.
Similar articles
-
Vagus somatosensory evoked potentials--a possibility for diagnostic improvement in patients with mild cognitive impairment?Dement Geriatr Cogn Disord. 2012;33(5):289-96. doi: 10.1159/000339359. Epub 2012 Jul 2. Dement Geriatr Cogn Disord. 2012. PMID: 22759638
-
Vagus somatosensory evoked potentials are delayed in Alzheimer's disease, but not in major depression.Eur Arch Psychiatry Clin Neurosci. 2014 Apr;264(3):263-7. doi: 10.1007/s00406-013-0415-2. Epub 2013 Jun 5. Eur Arch Psychiatry Clin Neurosci. 2014. PMID: 23736883
-
The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders.J Neural Transm (Vienna). 2015 Aug;122(8):1167-74. doi: 10.1007/s00702-014-1351-7. Epub 2014 Dec 18. J Neural Transm (Vienna). 2015. PMID: 25520210
-
Visual Event-Related Potentials in Mild Cognitive Impairment and Alzheimer's Disease: A Literature Review.Curr Alzheimer Res. 2019;16(1):67-89. doi: 10.2174/1567205015666181022101036. Curr Alzheimer Res. 2019. PMID: 30345915 Review.
-
Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.Acta Neurol Scand Suppl. 2003;179:34-41. Acta Neurol Scand Suppl. 2003. PMID: 12603249 Review.
Cited by
-
Micronucleus frequency in buccal mucosa cells of patients with neurodegenerative diseases.Sci Rep. 2020 Dec 17;10(1):22196. doi: 10.1038/s41598-020-78832-y. Sci Rep. 2020. PMID: 33335130 Free PMC article.
-
Evaluation of different vagus nerve stimulation anatomical targets in the ear by vagus evoked potential responses.Brain Behav. 2021 Nov;11(11):e2343. doi: 10.1002/brb3.2343. Epub 2021 Sep 22. Brain Behav. 2021. PMID: 34551214 Free PMC article.
-
A Systematic Review of Cerebral Functional Near-Infrared Spectroscopy in Chronic Neurological Diseases-Actual Applications and Future Perspectives.Diagnostics (Basel). 2020 Aug 12;10(8):581. doi: 10.3390/diagnostics10080581. Diagnostics (Basel). 2020. PMID: 32806516 Free PMC article. Review.
-
Functional near-infrared spectroscopy and vagus somatosensory evoked potentials add to the power of established parameters such as poor cognitive performance, dsyosmia and APOe genotype to predict cognitive decline over 8 years in the elderly.J Neural Transm (Vienna). 2024 Nov 13. doi: 10.1007/s00702-024-02859-y. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 39535568
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical